vs

Side-by-side financial comparison of Invivyd, Inc. (IVVD) and PROVIDENT FINANCIAL HOLDINGS INC (PROV). Click either name above to swap in a different company.

Invivyd, Inc. is the larger business by last-quarter revenue ($17.2M vs $9.8M, roughly 1.7× PROVIDENT FINANCIAL HOLDINGS INC). PROVIDENT FINANCIAL HOLDINGS INC runs the higher net margin — 14.6% vs -64.3%, a 78.9% gap on every dollar of revenue. On growth, Invivyd, Inc. posted the faster year-over-year revenue change (24.5% vs 2.5%).

Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.

Provident Financial Holdings Inc is a bank holding company operating through its subsidiary Provident Savings Bank. It offers retail and commercial banking services including deposit products, mortgage loans, consumer lending and small business financing for local communities across California.

IVVD vs PROV — Head-to-Head

Bigger by revenue
IVVD
IVVD
1.7× larger
IVVD
$17.2M
$9.8M
PROV
Growing faster (revenue YoY)
IVVD
IVVD
+22.0% gap
IVVD
24.5%
2.5%
PROV
Higher net margin
PROV
PROV
78.9% more per $
PROV
14.6%
-64.3%
IVVD

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
IVVD
IVVD
PROV
PROV
Revenue
$17.2M
$9.8M
Net Profit
$-11.1M
$1.4M
Gross Margin
Operating Margin
-73.0%
20.8%
Net Margin
-64.3%
14.6%
Revenue YoY
24.5%
2.5%
Net Profit YoY
40.0%
64.7%
EPS (diluted)
$0.02
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVVD
IVVD
PROV
PROV
Q4 25
$17.2M
$9.8M
Q3 25
$13.1M
$9.7M
Q2 25
$11.8M
$9.8M
Q1 25
$11.3M
$10.1M
Q4 24
$13.8M
$9.6M
Q3 24
$9.3M
$9.5M
Q2 24
$2.3M
$9.9M
Q1 24
$0
$9.4M
Net Profit
IVVD
IVVD
PROV
PROV
Q4 25
$-11.1M
$1.4M
Q3 25
$-10.5M
$1.7M
Q2 25
$-14.7M
$1.6M
Q1 25
$-16.3M
$1.9M
Q4 24
$-18.4M
$872.0K
Q3 24
$-60.7M
$1.9M
Q2 24
$-47.2M
$2.0M
Q1 24
$-43.5M
$1.5M
Operating Margin
IVVD
IVVD
PROV
PROV
Q4 25
-73.0%
20.8%
Q3 25
-84.0%
28.1%
Q2 25
-127.8%
23.6%
Q1 25
-149.7%
26.2%
Q4 24
-139.1%
12.7%
Q3 24
-670.0%
28.3%
Q2 24
-2175.2%
27.8%
Q1 24
22.5%
Net Margin
IVVD
IVVD
PROV
PROV
Q4 25
-64.3%
14.6%
Q3 25
-79.7%
17.3%
Q2 25
-124.4%
16.7%
Q1 25
-144.1%
18.4%
Q4 24
-133.5%
9.1%
Q3 24
-653.1%
20.0%
Q2 24
-2086.9%
19.7%
Q1 24
15.9%
EPS (diluted)
IVVD
IVVD
PROV
PROV
Q4 25
$0.02
$0.22
Q3 25
$-0.06
$0.25
Q2 25
$-0.12
$0.24
Q1 25
$-0.14
$0.28
Q4 24
$-0.14
$0.13
Q3 24
$-0.51
$0.28
Q2 24
$-0.40
$0.28
Q1 24
$-0.38
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVVD
IVVD
PROV
PROV
Cash + ST InvestmentsLiquidity on hand
$226.7M
$54.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$241.5M
$127.5M
Total Assets
$276.9M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVVD
IVVD
PROV
PROV
Q4 25
$226.7M
$54.4M
Q3 25
$85.0M
$49.4M
Q2 25
$34.9M
$53.1M
Q1 25
$48.1M
$50.9M
Q4 24
$69.3M
$45.5M
Q3 24
$106.9M
$48.2M
Q2 24
$147.9M
$51.4M
Q1 24
$189.4M
$51.7M
Stockholders' Equity
IVVD
IVVD
PROV
PROV
Q4 25
$241.5M
$127.5M
Q3 25
$93.1M
$128.4M
Q2 25
$42.8M
$128.5M
Q1 25
$54.1M
$128.9M
Q4 24
$67.5M
$128.6M
Q3 24
$83.2M
$129.6M
Q2 24
$140.6M
$129.9M
Q1 24
$178.5M
$129.5M
Total Assets
IVVD
IVVD
PROV
PROV
Q4 25
$276.9M
$1.2B
Q3 25
$139.2M
$1.2B
Q2 25
$89.1M
$1.2B
Q1 25
$103.7M
$1.3B
Q4 24
$129.5M
$1.3B
Q3 24
$161.9M
$1.3B
Q2 24
$177.3M
$1.3B
Q1 24
$215.5M
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVVD
IVVD
PROV
PROV
Operating Cash FlowLast quarter
$-15.5M
$1.2M
Free Cash FlowOCF − Capex
$1.0M
FCF MarginFCF / Revenue
10.5%
Capex IntensityCapex / Revenue
0.0%
1.9%
Cash ConversionOCF / Net Profit
0.85×
TTM Free Cash FlowTrailing 4 quarters
$14.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVVD
IVVD
PROV
PROV
Q4 25
$-15.5M
$1.2M
Q3 25
$-8.3M
$2.5M
Q2 25
$-13.3M
$8.7M
Q1 25
$-21.1M
$3.3M
Q4 24
$-37.6M
$324.0K
Q3 24
$-41.1M
$2.6M
Q2 24
$-41.6M
$5.7M
Q1 24
$-50.2M
$3.0M
Free Cash Flow
IVVD
IVVD
PROV
PROV
Q4 25
$1.0M
Q3 25
$2.5M
Q2 25
$-13.3M
$8.2M
Q1 25
$-21.3M
$3.3M
Q4 24
$-37.6M
$307.0K
Q3 24
$-41.1M
$2.4M
Q2 24
$4.1M
Q1 24
$-50.4M
$2.6M
FCF Margin
IVVD
IVVD
PROV
PROV
Q4 25
10.5%
Q3 25
25.2%
Q2 25
-112.9%
83.5%
Q1 25
-188.2%
32.5%
Q4 24
-272.2%
3.2%
Q3 24
-441.6%
25.1%
Q2 24
41.3%
Q1 24
27.5%
Capex Intensity
IVVD
IVVD
PROV
PROV
Q4 25
0.0%
1.9%
Q3 25
0.0%
0.5%
Q2 25
0.1%
5.4%
Q1 25
1.3%
0.3%
Q4 24
0.0%
0.2%
Q3 24
0.1%
1.8%
Q2 24
0.0%
16.0%
Q1 24
4.2%
Cash Conversion
IVVD
IVVD
PROV
PROV
Q4 25
0.85×
Q3 25
1.48×
Q2 25
5.34×
Q1 25
1.79×
Q4 24
0.37×
Q3 24
1.35×
Q2 24
2.91×
Q1 24
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons